Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies - Related Studies

Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies

This study has been completed.

Study NCT00004851. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Hepatitis C

2	Additional conditions recognized in this trial
		Hepatitis

3	More general conditions related to this trial
		Digestive System Diseases
		Flaviviridae Infections
		Hepatitis, Viral, Human
		Liver Diseases
		RNA Virus Infections
		Virus Diseases

4	Additional drug interventions recognized in this trial
		Hepatitis C Antibodies

5	More general drug interventions related to this trial
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs

6	Sponsors listed in this trial
		National Institutes of Health Clinical Center (CC)